Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Roberts

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Science Advances|June 12, 2019
Increasing mitigation ambition to meet the Paris Agreement's temperature goal avoids substantial heat-related mortality in U.S. citiesY T Eunice Lo, Daniel M Mitchell, Antonio Gasparrini, et al.
JCO Global Oncology|November 20, 2020
Improving Pediatric Neuro-Oncology Survival Disparities in the United States-Mexico Border Region: A Cross-Border Initiative Between San Diego, California, and Tijuana, MexicoPaula Aristizabal, Luke P Burns, Nikhil V Kumar, et al.
American Journal of Hematology|April 23, 2014
Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemiaKyle M Walsh, Adam J de Smith, Tara C Welch, et al.
American Journal of Clinical Pathology|July 2, 2002
Pediatric laboratory medicine: current challenges and future opportunitiesCheryl M Coffin, Marilyn S Hamilton, Theodore J Pysher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome ComparisonsJavier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 9, 2019
Balloon Dilation of the Eustachian Tube: 12-Month Follow-up of the Randomized Controlled Trial Treatment GroupVijay Anand, Dennis Poe, Marc Dean, et al.
International Journal of Cancer|May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastomaElizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
International Journal of Cancer|May 29, 2023
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastomaDon Eslin, Peter E Zage, Genevieve Bergendahl, et al.
Genes, Chromosomes & Cancer|May 19, 2019
Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in childrenAdam J de Smith, Geneviève Lavoie, Kyle M Walsh, et al.
Cancer Medicine|February 28, 2015
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastomaGiselle L Saulnier Sholler, Jeffrey P Bond, Genevieve Bergendahl, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Science Advances|June 12, 2019
Increasing mitigation ambition to meet the Paris Agreement's temperature goal avoids substantial heat-related mortality in U.S. citiesY T Eunice Lo, Daniel M Mitchell, Antonio Gasparrini, et al.
JCO Global Oncology|November 20, 2020
Improving Pediatric Neuro-Oncology Survival Disparities in the United States-Mexico Border Region: A Cross-Border Initiative Between San Diego, California, and Tijuana, MexicoPaula Aristizabal, Luke P Burns, Nikhil V Kumar, et al.
American Journal of Hematology|April 23, 2014
Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemiaKyle M Walsh, Adam J de Smith, Tara C Welch, et al.
American Journal of Clinical Pathology|July 2, 2002
Pediatric laboratory medicine: current challenges and future opportunitiesCheryl M Coffin, Marilyn S Hamilton, Theodore J Pysher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome ComparisonsJavier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 9, 2019
Balloon Dilation of the Eustachian Tube: 12-Month Follow-up of the Randomized Controlled Trial Treatment GroupVijay Anand, Dennis Poe, Marc Dean, et al.
International Journal of Cancer|May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastomaElizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
International Journal of Cancer|May 29, 2023
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastomaDon Eslin, Peter E Zage, Genevieve Bergendahl, et al.
Genes, Chromosomes & Cancer|May 19, 2019
Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in childrenAdam J de Smith, Geneviève Lavoie, Kyle M Walsh, et al.
Cancer Medicine|February 28, 2015
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastomaGiselle L Saulnier Sholler, Jeffrey P Bond, Genevieve Bergendahl, et al.
Pageof 9